(Source: Novo Nordisk) In September 2024: Eli Lilly reported positive Phase 3 results for retatrutide, a novel triple GLP-1/GIP/glucagon receptor agonist, demonstrating an average weight loss of 24.2% at 48 weeks in adults with obesity, representing the highest weight loss achieved with any pharmacological agent to date and approaching bariatric surgery efficacy
Negative List The FSQD noted that the product may have breached Section 13B(2)(d) of the Food Act 1983 , which prohibits the use of any unapproved or non-permitted substances in food products Regulatory Insights For Brand Owners Glutathione is prohibited in food supplements Any supplement containing glutathione is deemed non-compliant and subject to enforcement under Malaysias food and supplement regulations
On the grounds of the results obtained in the randomized double-blind trials, the authors did not confirm the effectiveness of feverfew in migraine treatment as compared with placebo [104]
For some IBS-D patients, the constipation side effect may reduce diarrhea
In vitro research on cut tendons suggests that BPC-157 may enhance the migration of tendon fibroblasts to sites of injury [8]
Quels sont les effets du glutathion sur la peau, concrtement